Clin2
NCT07734311Possibly a fitNot yet recruiting

Testing a weight-loss injection for knee arthritis pain

Knee OsteoarthritisObesity

Part of Bones, joints & muscles, Hormones & metabolism clinical trials.

This study tests whether an experimental weight-loss injection can reduce knee pain in people who are obese and have knee osteoarthritis. It may help if you have been unable to lose weight through diet and exercise and have moderate knee pain.

Summary written for real people, not researchers, by Clin2.

Phase
Phase 3
Enrollment
360 people
Ages
18 years to 75 years
Study type
Interventional

Who can take part

  • You must have a body mass index (BMI) of 28 or higher.
  • You must have knee osteoarthritis with moderate changes seen on X-ray (grade 2 or 3).
  • Your knee pain should have lasted more than 12 weeks, and you should have felt it on more than 15 days in the last month.
  • Your knee pain score should be between 4 and 9 on a 0-10 scale.
  • You must have tried diet and exercise to lose weight but not succeeded.
  • You must not have had knee replacement surgery or certain knee procedures recently.

View the official record on ClinicalTrials.gov

Quick eligibility check

Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.

Similar studies

Other trials that look related to this one.

NCT07509307Recruiting· Phase 3
Study of a new medicine for weight loss and knee pain in osteoarthritis

This trial tests if a new medicine, NNC0487-0111, can help people with excess weight and knee osteoarthritis lose weight and reduce knee pain. It is for people who have had knee pain for at least three months and who can stop taking pain relievers for short periods before study visits.

Escondido, California
NCT07481630Recruiting· Phase 3
Testing a new medicine for weight loss and knee pain

This study tests if a new medicine called NNC0487-0111 can help people with extra weight and knee osteoarthritis lose weight and reduce knee pain. If you have knee pain most days and are willing to stop pain relievers for short periods, you may be able to join.

Phoenix, Arizona
NCT06833749Recruiting· Phase 2
Testing KBP-336 for knee osteoarthritis with obesity

This study tests an experimental medicine called KBP-336 for people with both obesity and knee osteoarthritis who still have significant knee pain despite standard treatments. It aims to see if KBP-336 can reduce pain and improve function.

Brno
NCT07467447Recruiting· Phase 2
Testing a weight-loss drug for people with obesity or overweight

This trial tests whether an experimental drug (LY3437943) can help people with obesity or overweight lose weight. It compares the drug to a placebo (inactive shot), and you must be willing to give yourself daily injections.

Shenzhen, Guangdong
NCT07709910Not yet recruiting· Phase 3
A study of Ribupatide injection for weight loss and knee arthritis

This trial tests an injected medication to help people with obesity and knee osteoarthritis lose weight and improve joint pain. It may be a good option if you have struggled with weight and have knee arthritis.

Shanghai, Shanghai Municipality
NCT06884865Recruiting· Phase 2
Study of an experimental knee injection for osteoarthritis pain

This study tests a new investigational medicine injected into the knee to see if it is safe and tolerable for people with painful knee osteoarthritis. It may help reduce pain and improve knee function.

Birmingham, Alabama

Hear when a new Knee Osteoarthritis trial opens

We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.